Steroid Sparing Therapy

Advertisement

cGxPJobs Banner

Zenas BioPharma Reports Positive Phase 3 Obexelimab Results in IgG4-RD

WALTHAM, Mass., June 2, 2026 Zenas BioPharma, Inc. announced positive results from its registrational Phase 3 INDIGO trial evaluating...

By cGxPwire Editor
June 5, 2026

Read More

Advertisement

cGxPJobs

Directory